[THE PHYSIOLOGICAL INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. I. CONSUMPTION COAGULOPATHY IN THE SHWARTZMAN-SANARELLI PHENOMENON].
D000818:Animals; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D003029:Coagulants; D004211:Disseminated Intravascular Coagulation; D004731:Endotoxins; D004926:Escherichia coli; D006493:Heparin; D010827:Physiology; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; D011817:Rabbits; D012106:Research; D012790:Shwartzman Phenomenon
D001779:Blood Coagulation Factors; D003029:Coagulants; D004731:Endotoxins; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; D006493:Heparin
BLOOD COAGULATION FACTORS; ENDOTOXINS; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; HEPARIN; PHYSIOLOGY; POLYSACCHARIDES, BACTERIAL; RABBITS; SHWARTZMAN PHENOMENON
DIE PHYSIOLOGISCHEN INHIBITOREN DER BLUTGERINNUNG BEI PATHOLOGISCH GESTEIGERTER GERINNBARKEIT IN VIVO. I. VERBRAUCHSKOAGULOPATHIE BEIM SHWARTZMAN-SANARELLI-PHAENOMEN.